Historically, big pharma has invested massively, disproportionately, into drug discovery for western diseases, and what they call the lifestyle segment. These drugs don't optimise health gain in developing countries. Obviously some of the drugs they have developed are of relevance, HIV medicine in particular, which is the point of GSK's announcement. But if you look at where the R&D money has gone, it has gone into western disease drug discovery.
There has been some noise recently about this starting to change, but I wonder whether this is just spin: it's too soon to know.
Nay, I didnae.
Historically, big pharma has invested massively, disproportionately, into drug discovery for western diseases, and what they call the lifestyle segment. These drugs don't optimise health gain in developing countries. Obviously some of the drugs they have developed are of relevance, HIV medicine in particular, which is the point of GSK's announcement. But if you look at where the R&D money has gone, it has gone into western disease drug discovery.
There has been some noise recently about this starting to change, but I wonder whether this is just spin: it's too soon to know.